drugset / Trial / NCT00527930
Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer
Phase 2
Completed
87 enrolled
Seoul National University Hospital
Asan Medical Center · collabKorean Cancer Study Group · collabNational Cancer Center, Korea · collabSamsung Medical Center · collabSeoul National University Bundang Hospital · collabSeverance Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial of oxaliplatin in combination with S-1(SOX) in patients with recurrent or metastatic breast cancer (MBC) previously treated with or resistant to an anthracycline and taxane
Timeline
- Start
- 2007-09
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | 130 mg/m2 | Intravenous |
| Subject | S-1 | Small molecule | 80 mg/m2 | — |